Moleculin Biotech
MBRX
MBRX
23 hedge funds and large institutions have $1.44M invested in Moleculin Biotech in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
Renaissance Technologies
New York
|
-$19.5K |
2 |
UBS Group
Zurich,
Switzerland
|
-$15.2K |
3 |
AWM
Atticus Wealth Management
Palm Beach Gardens,
Florida
|
-$4.73K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.61K |
5 |
Bank of America
Charlotte,
North Carolina
|
-$70 |